HEPATIC SARCOIDOSIS
Abstract
Sarcoidosis is a multisystemic disease of unknown origin characterized by the formation of non caseating granulomas. Thoracic involvement is the most common presentation; however, sarcoidosis can involve almost any other organ. Liver is one of the most frequently affected organs after lungs and lymph nodes. Microscopic hepatic involvement is common in these patients but is mostly clinically silent. specific symptoms include jaundice and pruritus, mostly from chronic cholestasis. In a significant portion of these patients, macroscopic findings can be detected by ultrasound examination , abdominal CT or magnetic resonance imaging and these findings may easily be confused with other benign and malignant conditions of the liver. Liver biopsy is usually required to confirm the diagnosis. Not all cases of hepatic sarcoidosis require treatment. For symptomatic patients, the first line treatment includes corticosteroids or ursodeoxycholic acid.
About the Authors
M. F. Osipenko
Novosibirsk State University
Russian Federation
Russian Federation
N. B. Voloshina
Novosibirsk State University
Russian Federation
Russian Federation
References
1. Tadros M., Forouhar F., Wu G. Y. Hepatic Sarcoidosis. Journal of Clinical and Translational Hepatology; 2013, vol. 1, pp. 87-93.
2. Culver D. A. Sarcoidosis. Immunol Allergy Clin North Am, 2012, vol. 32, pp. 487-511.
3. Baughman R. P., Lower E. E. Sarcoidosis. Harrison’s Principles of Internal Medicine, 2008, pp. 2135-2142.
4. Coash M., Forouhar F., Wu CH, Wu G. Y. Granulomatous liver diseases: A review. J Formos Med Assoc, 2012, vol. 111, pp. 3-13.
5. Iannuzzi M. C., Rybicki B. A., Teirstein A. S. Sarcoidosis. N Engl J Med, 2007, vol. 357, pp. 2153-2165.
6. Belfer M. H., Stevens R. W. Sarcoidosis: A primary care review. Am Fam Physician, 1998, vol. 58, pp. 2041-2050.
7. Takahashi N., HorieT. Heerfordt syndrome. Nihon Rinsho Jpn J Clin Med, 2002, vol. 60, pp. 1822-1826.
8. Zissel G., Prasse A., Muller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med, 2010, vol. 31, pp. 390-403.
9. Chesnutt M. S., Gifford A. H., Prendergast T. J. Pulmonary disorders. Current medical diagnosis & treatment, 2010.
10. Lazarus A. Sarcoidosis: Epidemiology, Etiology, Pathogenesis, and Genetics. Dis Mon, 2009, vol. 55, pp. 649-660.
11. Chen E. S. D., Moller D. R. Sarcoidosis. Current Rheumatology Diagnosis and Treatment, 2004.
12. Dulai P. S., Rothstein R. I. Disseminated sarcoidosis presenting as granulomatous gastritis: A clinical review of the gastrointestinal and hepatic manifesta- tions of sarcoidosis. J Clin Gastroenterol, 2012, vol. 46, pp. 367-374.
13. Harder H., Buchler M. W., Frohlich B. Strobel P. et al. Extrapulmonary sarcoidosis of liver and pancreas: A case report and review of literature. World J Gastroenterol, 2007, vol. 13, pp. 2504-2509.
14. Israel H. L., Margolis M. L., Rose L. J. Hepatic granulomatosis and sarcoidosis - Further observations. Dig Dis Sci, 1984, vol. 29, pp. 353-356.
15. Vanatta J. M., Modanlou K. A., Dean A. G. et al. Outcomes of orthotopic liver transplantation for hepatic sarcoidosis: An analysis of the United Network for organ sharing/organ Procurement and Transplantation Network data files for a comparative study with cholestatic liver diseases. Liver Transpl, 2011, vol. 17, pp. 1027-1034.
16. Blich M., Edoute Y. Clinical manifestations of sarcoid liver disease. J Gastroenterol Hepatol, 2004, vol. 19, pp. 732-737.
17. Malhotra A., Naniwadekar A., Sood G. Hepatobiliary and pancreatic: Cirrhosis secondary to hepatic sarcoidosis. J Gastroenterol Hepatol, 2008, vol. 23, pp. 1942.
18. Gupta S., Faughnan M. E., Prudhomme G. J. et al. Sarcoidosis complicated by cirrhosis and hepatopulmonary syndrome. Can Respir J, 2008, vol. 15, pp. 124-126.
19. Cremers J., Drent M., Driessen A. et al. Liver-test abnormalities in sarcoidosis. Eur J Gastroenterol Hepatol, 2012, vol. 24, pp. 17- 24.
20. Silverstein E., Friedland J., Kitt M., Lyons H. A. Increased serum angiotensin converting enzyme activity in sarcoidosis. Isr J Med Sci, 1977, vol. 13, pp. 995-10-00
21. Lieberman J. Elevation of serum angiotension converting enzyme (ACE) level in sarcoidosis. Am J Med, 1975, vol. 59, pp. 365-372.
22. Studdy P. R., Bird R. Serum angiotensin converting enzyme in sarcoidosis - Its value in present clinical practice. Ann Clin Biochem, 1989, vol. 26, pp. 13-18.
23. Moller D. R. Treatment of sarcoidosis - from a basic science point of view. J Intern Med, 2003, vol. 253, pp. 31-40.
24. Ebert E. C., Kierson M., Hagspiel K. D. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol, 2008, vol. 103, pp. 3184-3192.
25. Rose A. S., Tielker M. A., Knox K. S. Hepatic, Ocular, and Cutaneous Sarcoidosis. Clin Chest Med, 2008, vol. 29, pp. 509-524.
26. MacArthur K. L., Forouhar F., Wu G. Y. Intra-abdominal complications of sarcoidosis. J Formos Med Assoc, 2010, vol. 109, pp. 484-492.
27. Bakker G. J., Haan Y. C., Maillette de Buy Wenniger L. J., Beuers U. Sarcoidosis of the liver: to treat or not to treat? Neth J Med, 2012, vol. 70, pp. 349-356.
28. Blich M, Edoute Y. Clinical manifestations of sarcoid liver disease. J Gastroenterol Hepatol 2004;19:732-737.
29. Malhotra A, Naniwadekar A, Sood G. Hepatobiliary and pancreatic: Cirrhosis secondary to hepatic sarcoidosis. J Gastroenterol Hepatol 2008; 23:1942
30. Gupta S, Faughnan ME, Prud’homme GJ, Hwang DM, Munoz DG, Kopplin P. Sarcoidosis complicated by cirrhosis and hepatopulmonary syndrome. Can Respir J 2008;15:124-126.
Review
For citations:
Osipenko M.F., Voloshina N.B. HEPATIC SARCOIDOSIS. Experimental and Clinical Gastroenterology. 2016;(9):86-90. (In Russ.)
Views:
2290
Email this article 